{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T16:04:56Z","timestamp":1772467496449,"version":"3.50.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T00:00:00Z","timestamp":1566000000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T00:00:00Z","timestamp":1566000000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s10072-019-04038-4","type":"journal-article","created":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T18:02:40Z","timestamp":1566064960000},"page":"221-223","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Anti-MuSK ocular myasthenia with extrinsic ocular muscle atrophy: a new clinical phenotype?"],"prefix":"10.1007","volume":"41","author":[{"given":"Dario","family":"Ricciardi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Todisco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gioacchino","family":"Tedeschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3183-8773","authenticated-orcid":false,"given":"Giovanni","family":"Cirillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,17]]},"reference":[{"issue":"10","key":"4038_CR1","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","volume":"14","author":"NE Gilhus","year":"2015","unstructured":"Gilhus NE, Verschuuren JJ (2015) Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol 14(10):1023\u20131036","journal-title":"Lancet Neurol"},{"issue":"3","key":"4038_CR2","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s13760-018-0943-7","volume":"118","author":"G Galassi","year":"2018","unstructured":"Galassi G, Mazzoli M, Ariatti A, Kaleci S, Valzania F, Nichelli PF (2018) Antibody profile may predict outcome in ocular myasthenia gravis. Acta Neurol Belg 118(3):435\u2013443","journal-title":"Acta Neurol Belg"},{"issue":"9","key":"4038_CR3","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1136\/jnnp-2017-315782","volume":"88","author":"A Evoli","year":"2017","unstructured":"Evoli A, Alboini PE, Iorio R, Damato V, Bartoccioni E (2017) Pattern of ocular involvement in myasthenia gravis with MuSK antibodies. J Neurol Neurosurg Psychiatry 88(9):761\u2013763","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4038_CR4","first-page":"1002","volume":"62","author":"JB Caress","year":"2005","unstructured":"Caress JB, Hunt CH, Batish SD (2005) Anti-MuSK myasthenia gravis presenting with purely ocular findings. Arch Neurol 62:1002\u20131003","journal-title":"Arch Neurol"},{"key":"4038_CR5","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00415-005-0032-8","volume":"253","author":"F Hanisch","year":"2006","unstructured":"Hanisch F, Eger K, Zierz S (2006) MuSK-antibody positive pure ocular myasthenia gravis. J Neurol 253:659\u2013660","journal-title":"J Neurol"},{"key":"4038_CR6","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1136\/jnnp.2005.075812","volume":"77","author":"DL Bennett","year":"2006","unstructured":"Bennett DL, Mills KR, Riordan-Eva P, Barnes PR, Rose MR (2006) Anti-MuSK antibodies in a case of ocular myasthenia gravis. J Neurol Neurosurg Psychiatry 77:564\u2013565","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"21","key":"4038_CR7","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.2169\/internalmedicine.51.8196","volume":"51","author":"A Hosaka","year":"2012","unstructured":"Hosaka A, Takuma H, Ohta K, Tamaoka A (2012) An ocular form of myasthenia gravis with a high titer of anti-MuSK antibodies during a long-term follow-up. Intern Med 51(21):3077\u20133079","journal-title":"Intern Med"},{"issue":"3","key":"4038_CR8","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1002\/mus.23847","volume":"48","author":"V Zouvelou","year":"2013","unstructured":"Zouvelou V, Papathanasiou A, Koros C, Rentzos M, Zambelis T, Stamboulis E (2013) Pure ocular anti-musk myasthenia under no immunosuppressive treatment. Muscle Nerve 48(3):464","journal-title":"Muscle Nerve"},{"key":"4038_CR9","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1136\/bjo.2006.108498","volume":"91","author":"JW Chan","year":"2007","unstructured":"Chan JW, Orrison WW (2007) Ocular myasthenia: a rare presentation with MuSK antibody and bilateral extraocular muscle atrophy. Br J Ophthalmol 91:842\u2013843","journal-title":"Br J Ophthalmol"},{"issue":"1\u20132","key":"4038_CR10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jneuroim.2006.05.017","volume":"177","author":"N Boneva","year":"2006","unstructured":"Boneva N, Frenkian-Cuvelier M, Bidault J, Brenner T, Berrih-Aknin S (2006) Major pathogenic effects of anti-MuSK antibodies in myasthenia gravis. J Neuroimmunol 177(1\u20132):119\u2013131","journal-title":"J Neuroimmunol"},{"issue":"6","key":"4038_CR11","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1136\/jnnp.2009.171793","volume":"81","author":"H Takahashi","year":"2010","unstructured":"Takahashi H, Kawaguchi N, Ito S, Nemoto Y, Hattori T, Kuwabara S (2010) Is tongue atrophy reversible in anti-MuSK myasthenia gravis? Six-year observation. J Neurol Neurosurg Psychiatry 81(6):701\u2013702","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-019-04038-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-019-04038-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-019-04038-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T23:59:10Z","timestamp":1597535950000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-019-04038-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,17]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["4038"],"URL":"https:\/\/doi.org\/10.1007\/s10072-019-04038-4","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,17]]},"assertion":[{"value":"15 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The patient provided written informed consent, approved by the local Ethics Committee of the University of Campania \u201cLuigi Vanvitelli.\u201d","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}